J. Smits

ORCID: 0000-0001-9828-0407
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pulmonary Hypertension Research and Treatments
  • Liver Disease and Transplantation
  • Cancer-related molecular mechanisms research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • Transplantation: Methods and Outcomes
  • Anesthesia and Sedative Agents
  • Fibroblast Growth Factor Research
  • Pediatric Hepatobiliary Diseases and Treatments
  • Angiogenesis and VEGF in Cancer
  • Extracellular vesicles in disease
  • Cardiovascular Function and Risk Factors
  • Vascular Anomalies and Treatments
  • Heart Failure Treatment and Management
  • Chronic Myeloid Leukemia Treatments
  • Nausea and vomiting management
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Atrial Fibrillation Management and Outcomes
  • Congenital Heart Disease Studies
  • Congenital heart defects research
  • Tracheal and airway disorders
  • Chronic Lymphocytic Leukemia Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Acute Lymphoblastic Leukemia research

Vrije Universiteit Amsterdam
2020-2023

Amsterdam University Medical Centers
2018-2023

Amsterdam Neuroscience
2023

Maastricht University
2023

Amsterdam UMC Location Vrije Universiteit Amsterdam
2018-2022

Pulmonary Associates
2017

Stichting tot Steun VCVGZ
1978

Sjors G. J. G. In ‘t Veld Mohammad Arkani Edward P. Post Mafalda Antunes‐Ferreira Silvia D’Ambrosi and 95 more Daan C.L. Vessies Lisa Vermunt Adrienne Vancura Mirte Muller Anna-Larissa N. Niemeijer Jihane Tannous Laura L. Meijer Tessa Y. S. Le Large Giulia Mantini Niels E. Wondergem Kimberley M. Heinhuis Sandra van Wilpe J. Smits Esther E.E. Drees Eva Roos Cyra E Leurs Lee-Ann Tjon Kon Fat Ewoud J. van der Lelij Govert Dwarshuis Maarten J. Kamphuis Lisanne E. Visser Romée Harting Annemijn Gregory Markus Schweiger Laurine E. Wedekind Jip Ramaker Kenn Zwaan Heleen Verschueren Idris Bahce Adrianus J. de Langen Egbert F. Smit Michel M. van den Heuvel Koen J. Hartemink Marijke J. E. Kuijpers Mirjam G.A. oude Egbrink Arjan W. Griffioen Rafael Rossel T. Jeroen N. Hiltermann Elizabeth Lee-Lewandrowski Kent Lewandrowski Philip C. De Witt Hamer Mathilde C.M. Kouwenhoven Jaap C. Reijneveld William P. J. Leenders Ann Hoeben Irma M. Verdonck‐de Leeuw C. René Leemans Robert J. Baatenburg de Jong Chris H.J. Terhaard Robert P. Takes Johannes A. Langendijk Saskia C.A. de Jager Adriaan O. Kraaijeveld Gerard Pasterkamp Minke Smits Jack A. Schalken Sylwia Łapińska‐Szumczyk Anna Łojkowska Anna J. Żaczek Henk M. Lokhorst Niels W.C.J. van de Donk Inger S. Nijhof Henk-Jan Prins Josée M. Zijlstra Sander Idema Johannes C. Baayen Charlotte E. Teunissen Joep Killestein Marc G. Besselink Lindsay Brammen Thomas Bachleitner‐Hofmann Farrah J. Mateen John Th. M. Plukker Michal Heger Quirijn de Mast Ton Lisman D. Michiel Pegtel Harm Jan Bogaard Jacek Jassem Anna Supernat Niven Mehra Winald R. Gerritsen Cor D. de Kroon Christianne Lok Jurgen M.J. Piek Neeltje Steeghs Winan J. van Houdt Ruud H. Brakenhoff Gabe S. Sonke Henk M.W. Verheul Elisa Giovannetti Geert Kazemier Siamack Sabrkhany Ed Schuuring Erik A. Sistermans

Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets involved in cancer progression and considered a promising biosource detection, as they alter their RNA content upon local systemic cues. We show that tumor-educated platelet (TEP) RNA-based blood tests enable the of 18 types. With 99% specificity asymptomatic controls, thromboSeq correctly detected presence two-thirds 1,096 samples stage I–IV half 352 I–III...

10.1016/j.ccell.2022.08.006 article EN cc-by Cancer Cell 2022-09-01

The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental early clinical data suggest that the tyrosine-kinase inhibitor imatinib reverses pulmonary leak. This randomised, double-blind, placebo-controlled, trial was done at 13 academic non-academic teaching hospitals in Netherlands. Hospitalised patients (aged ≥18 years) with COVID-19, as confirmed by an RT-PCR test for SARS-CoV-2, requiring supplemental oxygen to maintain a...

10.1016/s2213-2600(21)00237-x article EN cc-by The Lancet Respiratory Medicine 2021-06-18

BackgroundTo investigate the association between altered sex hormone expression and long-term right ventricular (RV) adaptation progression of heart failure in a Dutch cohort Pulmonary Arterial Hypertension (PAH)-patients across wide range ages.MethodsIn this study we included 279 PAH-patients, which 169 females 110 males. From 59 patients 21 controls collected plasma samples for analysis. Right catheterization (RHC) and/or cardiac magnetic resonance (CMR) imaging was performed at baseline....

10.1016/j.healun.2021.11.004 article EN cc-by The Journal of Heart and Lung Transplantation 2021-11-14

In pulmonary arterial hypertension (PAH), lung-angioproliferation leads to increased vascular resistance, while simultaneous myocardial microvessel loss contributes right ventricular (RV) failure. Endothelial colony forming cells (ECFC) are highly proliferative, angiogenic that may contribute either obstruction or RV microvascular adaptation. We hypothesize ECFC phenotypes (outgrowth, proliferation, tube formation) related markers of disease severity in a prospective cohort-study 33 PAH and...

10.3390/ijms19123763 article EN International Journal of Molecular Sciences 2018-11-27

Background Pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension improves resting hemodynamics and right ventricular (RV) function. Because exercise tolerance frequently remains impaired, RV function may not have completely normalized after PEA. Therefore, we performed a detailed invasive hemodynamic study to investigate the effect of PEA on during exercise. Methods Results In this prospective study, all consenting patients with eligible surgery able perform cycle...

10.1161/jaha.122.027638 article EN cc-by-nc-nd Journal of the American Heart Association 2023-02-21

Domperidone was compared with placebo in a multicenter double-blind study of 116 patients (15 to 80 years) postoperative vomiting. After vomiting had occurred, the received either domperidone 10 mg or IV. Patients were then followed for at least 6 hours until 2nd injection from an open supply needed. The period time additional registered and between 2 treatment groups. Fifty-nine percent needed before end 6-hour follow-up, only 35% (p<0.05). When required, elapsed it longer (p = 0.01) group...

10.1213/00000539-197811000-00019 article EN Anesthesia & Analgesia 1978-11-01

Rationale: Pulmonary hypertension encompasses progressive disorders leading to right ventricular dysfunction and early death. Late detection is an important cause of poor clinical outcomes. However, biomarkers that accurately predict the presence pulmonary are currently lacking. Objectives: In this study, we provide evidence blood platelets contain a distinctive ribonucleic acid (RNA) profile may be exploited for hypertension. Methods: Blood platelet RNA was isolated prospectively from 177...

10.1513/annalsats.202201-085oc article EN Annals of the American Thoracic Society 2022-05-10

In Pulmonary Arterial Hypertension (PAH) structural and functional abnormalities in the lung lead to an increased pulmonary vascular resistance right heart failure. Dysfunction of pressure-regulating endothelial cells (ECs) is thought play crucial role. Recently it was shown our laboratory that biopsy derived microvascular ECs (MVECs) from PAH-patients are unable align under 120h high shear stress. As availability these limited, a suitable alternative needed. Our aim investigate ECFC as...

10.1183/13993003.congress-2015.pa2444 article EN 2015-09-01

Background Appropriate treatment of pulmonary hypertension (PH) is critically dependent on accurate discrimination between pre- and postcapillary PH. However, clinical challenging frequently requires a right heart catheterization. Existing risk scores to detect PH have suboptimal discriminatory strength. We previously shown that platelet-derived RNA profiles may diagnostic value for detection. Here, we hypothesize RNAs can be employed select unique biomarker panels the Methods Results Blood...

10.1161/jaha.122.028447 article EN cc-by-nc-nd Journal of the American Heart Association 2023-06-22

Pulmonary arterial hypertension (PAH) is associated with angioproliferation in the lung and, paradoxically, vascular rarefaction right ventricle (RV). Endothelial colony forming cells (ECFC) are angioproliferative endothelial implicated tissue repair. Here we investigated wether ECFC characteristics correlate disease severity, pulmonary resistance (PVR) and RV-function. <b>Methods:</b> were collected from 36 PAH 21 healthy donors. Proliferation angiogenic capacity upon GF stimulation...

10.1183/13993003.congress-2018.pa3934 article EN 13.01 - Pulmonary hypertension 2018-09-15

HR 0.51 {95%CI 0.27 to 0.96}, P=0.03) Bleeding events, especially intracranial bleeding, were lower in the combined therapy arms, but gastric bleeding was more frequent with this therapy.In summary: events-rate during antithrombotic similar nonvalvular and MS Pts, despite Pts younger than AF patients have significantly incidence of another risk factors.Pts prior embolism a higher new vascular events spite Aco therapy.Combined reduced compared alone.

10.1093/europace/7.s1.121-a article EN EP Europace 2005-01-01

<b>Background:</b> Discrimination between pre- and post-capillary Pulmonary Hypertension (PH) is challenging often requires invasive right heart catherization. Platelet-derived RNA signatures may have predictive value for tumour diagnostics. We hypothesize that platelet can be exploited to select unique biomarker RNA-panels the distinction post- pre-capillary PH. <b>Method:</b> isolated platelets from whole blood 50 PH patients. Platelet pellets were subjected total isolation, SMARTer cDNA...

10.1183/13993003.congress-2020.1526 article EN 13.01 - Pulmonary hypertension 2020-09-07

<b>Introduction:</b> COVID-19 is often complicated by hypoxemic respiratory failure, resulting from widespread capillary leak. The kinase inhibitor imatinib may protect the endothelial barrier and reverse pulmonary <b>Methods:</b> This was&nbsp;a randomized, double-blind, placebo-controlled trial. Hospitalized patients requiring supplemental oxygen were randomized to oral (800mg loading dose, followed 400mg daily for 9 days) or placebo on top of standard care. primary outcome was time...

10.1183/13993003.congress-2021.oa4119 article EN 03.02 - Airway cell biology and immunopathology 2021-09-05
Coming Soon ...